SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-003759
Filing Date
2020-02-07
Accepted
2020-02-06 18:03:27
Documents
1
Period of Report
2020-02-06
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K prnb-8k_20200205.htm 8-K 32521
  Complete submission text file 0001564590-20-003759.txt   33572
Mailing Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Filer) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38653 | Film No.: 20583969
SIC: 2834 Pharmaceutical Preparations